All Blogs
Tech Watch: Sensing, Pumps, Access Gaps and Paying for Outcomes
Diabetes technology continued to move towards devices that do more with less effort from the person wearing them. On 26 August 2026, the US ...
View →
Screening Children for Type 1 Diabetes: Evidence from Milan That Europe Is Ready
For a family, a diagnosis of type 1 diabetes often arrives in an emergency department, with a child already seriously ill from diabetic keto...
View →
Responsible Artificial Intelligence in Diabetes Care: The IDF Perspective at EASD 2026
Artificial intelligence is already part of diabetes care. Insulin pumps that adjust doses automatically, software that predicts low blood gl...
View →
EASD 2026: PDGN Brings the Parliamentary Voice to Milan
The European Association for the Study of Diabetes (EASD) held its annual meeting in Milan from 28 September to 2 October 2026, bringing tog...
View →
Ending Diabetes Stigma: From the Cockpit to the Workplace
Stigma follows people with diabetes into places that have little to do with their health: the job interview, the licensing office, the conve...
View →
Diabetes and Development: Warnings from South Africa and Mexico
Diabetes is now among the leading causes of death in several middle-income countries, a trend that threatens progress towards Sustainable De...
View →
Every Child Counts: Earlier Detection and Better Support for Type 1 Diabetes
Our last edition told the story of Lyla Story and the campaign for earlier testing of children in the United Kingdom. This quarter, the inte...
View →
Parliaments and Courts Reshape Food Environments
People make food choices within environments they did not design. Labels that are hard to read, aggressive marketing to children and cheap u...
View →
Sugary Drink Taxes: Growing Momentum, Persistent Resistance
Taxes on sugar sweetened beverages are among the most studied tools for preventing type 2 diabetes. This quarter brought new evidence on how...
View →
Diabetes Care When Systems Are Under Strain
Diabetes does not pause for conflict, displacement or economic hardship. Insulin must be taken every day, kept at the right temperature and ...
View →
Generic Semaglutide Arrives: A New Opening for Access
As patents on semaglutide expire in several countries, regulators are approving the first generic and lower cost versions of one of the most...
View →
Securing the World's Insulin Supply: New Producers, Persistent Gaps
A century after its discovery, insulin remains concentrated in the hands of a few manufacturers, and people living with diabetes feel every ...
View →
Insulin Affordability: Congress Hears the Patient Voice
For many Americans living with diabetes, the cost of insulin still shapes daily decisions about health. New evidence released this quarter s...
View →
Parliamentarians Gather in Melbourne to Lead on Diabetes Across the Western Pacific
More than 215 million adults in the Western Pacific live with diabetes, a number projected to reach 254 million by 2050. Each of them is a p...
View →
When Regulation Shapes Access: Why the ISLET Act Matters for Type 1 Diabetes
Across the diabetes policy landscape, innovation is moving fast but regulation often determines who actually benefits.In the United States, ...
View →
Addressing Diabetes Stigma Through Leadership and Policy
Reflections from the World Diabetes Day panel in MaltaIn November, within the Parliament of Malta, a dedicated panel discussion brought focu...
View →
Lyla’s Law: Call for Mandatory Type 1 Diabetes Screening for Children Gains Political Momentum
A growing campaign in the United Kingdom is calling for mandatory early screening for Type 1 diabetes in children following the tragic death...
View →
Listening to the Frontlines: What the Diabetes Community Is Asking of Parliaments
Recently, we asked the diabetes community a few simple but powerful questions.What is the biggest barrier to effective diabetes policy in yo...
View →
Why Diabetes Is a Parliamentary Issue, Not Just a Health One
Why leadership from lawmakers matters in 2026?Diabetes is often spoken about as a medical condition. Doctor visits. Prescriptions. Blood sug...
View →
Turning Policy into Practice: A Call to Action on Diabetes
Reflections from Dr Sandesh Gulhane MSP following the Parliamentarians for Diabetes Global Network Conference, MaltaThere is no single polic...
View →